Peremans Kathelijne, De Spiegeleer Bart, Buntinx Erik, Dobbeleir Andre, Vermeire Simon, Vandermeulen Eva, De Vos Filip, Megens Anton, Eersels Jos, Audenaert Kurt
Medical Imaging Department, Faculty of Veterinary Medicine, Laboratory of Radiopharmacy, Ghent University, Ghent, Belgium.
Nucl Med Commun. 2008 Aug;29(8):724-9. doi: 10.1097/MNM.0b013e3282fdc989.
To conduct a cost-efficient pilot study on the effect of low-dose pipamperone on the serotonin-2A receptor binding in a large animal model with conventional single-photon emission tomography modalities.
Three healthy drug-naive female Beagle dogs were scanned before and after administration of a single-dose pipamperone of 5 and 10 mg. Acquisition was performed under general anesthesia 90 min after injection of the specific radioligand 123I-5-I-R91150 with a triple head gamma-camera (Triad, Trionix). Binding index and receptor occupancy were calculated on the emission data after image fusion with the emission data from the individual 99mTc-ethyl cysteinate dimer perfusion scans to optimize frontal cortex delineation.
A dose-dependent reduction of the binding index was observed after single low-dose pipamperone, suggestive for competition of this cold compound with the radioligand for the 5-HT2A receptor. The calculated mean-binding serotonin-2A binding index in the frontal cortex was 1.47 before treatment and reduced to 1.28 after one dose of pipamperone 5 mg and to 1.08 after one dose of pipamperone 10 mg. The calculated occupancy was 40.4% after one dose of 5 mg pipamperone and 83% after one dose of 10 mg pipamperone.
This experiment supports the hypothesis that pipamperone, even in the low-dose range, significantly blocks serotonin-2A receptors. This study also demonstrates the value of the canine model to investigate the effects of drugs on neurotransmitter systems. Repeated nuclear imaging brain scanning experiments with different paradigms and medication doses are possible with conventional imaging equipment in a well-accepted laboratory species.
采用传统单光子发射断层扫描方式,在大型动物模型中开展一项关于低剂量匹泮哌隆对5-羟色胺-2A受体结合影响的成本效益型初步研究。
三只健康的未用过药的雌性比格犬在给予5毫克和10毫克单剂量匹泮哌隆前后进行扫描。在注射特异性放射性配体123I-5-I-R91150 90分钟后,在全身麻醉下使用三头γ相机(Triad,Trionix)进行采集。将发射数据与个体99mTc-半胱氨酸乙酯二聚体灌注扫描的发射数据进行图像融合,以优化额叶皮层的描绘,然后根据发射数据计算结合指数和受体占有率。
单次低剂量匹泮哌隆给药后,观察到结合指数呈剂量依赖性降低,提示这种非放射性化合物与放射性配体竞争5-HT2A受体。治疗前额叶皮层计算得出的平均5-羟色胺-2A结合指数为1.47,一剂5毫克匹泮哌隆后降至1.28,一剂10毫克匹泮哌隆后降至1.08。计算得出的占有率在一剂5毫克匹泮哌隆后为40.4%,在一剂10毫克匹泮哌隆后为83%。
本实验支持以下假设:即使在低剂量范围内,匹泮哌隆也能显著阻断5-羟色胺-2A受体。本研究还证明了犬模型在研究药物对神经递质系统影响方面的价值。在一个广泛接受的实验动物物种中,使用传统成像设备进行不同范式和药物剂量的重复核成像脑部扫描实验是可行的。